MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-06-0004118
Dexbio Pharma Private Limited
Dexbio Pharma Private Limited - pharma in Roorkee, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹21.52 Cr
▲ 18% YoY
Net profit · FY 2025
₹73.44 Lakh
Net margin 3.4%
EBITDA · FY 2025
₹2.49 Cr
EBITDA margin 11.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹14.53 Cr
Satisfied ₹11.96 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
27
Provident fund records
About Dexbio Pharma Private Limited
Data last updated:
Dexbio Pharma Private Limited is a private limited company based in Roorkee, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24232UR2006PTC011840. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Venkata Subbarao and Anshul Chhabra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 134/2 Khasra No 4M Shiv Ganga Industrial Estate, Roorkee, Uttarakhand, India – 247667.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.52 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹73.44 Lakh (net margin 3.4%) and EBITDA of ₹2.49 Cr (EBITDA margin 11.5%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 12% over five years.
The company has about 27 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹14.53 Cr and satisfied charges of ₹11.96 Cr on record. Court records list 20 cases involving the company, including 5 filed by the company and 15 filed against it; 2 cases are pending.
Dexbio Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0004118). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232UR2006PTC011840
Registration Number 011840
Incorporation Date 31 May 2006
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0004118
CIN history
Dexbio Pharma has one previous CIN (Corporate Identification Number): U24232PY2006PTC001959. The current CIN is U24232UR2006PTC011840, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232UR2006PTC011840 | Current |
| U24232PY2006PTC001959 | Previous |
Recognitions & Rankings of Dexbio Pharma
Contact details
Dexbio Pharma Private Limited's registered office is in Roorkee, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address134/2 Khasra No 4M Shiv Ganga Industrial Estate, Roorkee, Uttarakhand, India – 247667
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dexbio Pharma Private Limited, buy the company report.
Comprehensive company report
Dexbio Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dexbio Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dexbio Pharma Private Limited, buy the company report.
Financials of Dexbio Pharma Private Limited
FY 2025 filings availableDexbio Pharma Private Limited reported revenue of ₹21.52 Cr (up 18% YoY) for FY 2025.
Revenue · FY 2025
₹21.52 Cr ▲ 18%
Net profit · FY 2025
₹73.44 Lakh margin 3.4%
EBITDA · FY 2025
₹2.49 Cr margin 11.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 1%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 103%
3 years · compounded
▲ 33%
5 years · compounded
▲ 23%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 18% growth in the latest year. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹21.52 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.49 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹73.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.5% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dexbio Pharma Private Limited, buy the company report.
Board of directors of Dexbio Pharma Private Limited
Dexbio Pharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Subbarao | Director | 23 Aug 2006 | 20 Years 2 Months | Current |
| Anshul Chhabra | Director | 23 Apr 2018 | 8 Years 6 Months | Current |
| Venkata Rangaiah Kothuri Also directs: Dexbio Life Sciences Private Limited | Director | 23 Aug 2006 | 20 Years 2 Months | Current |
| Rajeev Kumar Chhabra | Director | 23 Apr 2018 | 8 Years 6 Months | Current |
Peer comparison
Dexbio Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dexbio Pharma Private Limitedthis company | ₹21.52 Cr (FY 2025) | ₹73.44 Lakh | 3.4% | 18.0% | 27 | Roorkee, Uttarakhand, India |
| Sunrise International Labs Limited | ₹21.39 Cr (FY 2024) | 6.0% | Hyderabad, Telangana, India | |||
| Ce-Chem Pharmaceuticals Private Limited | ₹21.36 Cr (FY 2025) | 53.0% | Bangalore, Karnataka, India | |||
| Dios Lifesciences Private Limited | ₹21.24 Cr (FY 2024) | 44.0% | New Delhi, Delhi, India | |||
| Elfin Drugs Private Limited | ₹21.23 Cr (FY 2024) | 15.0% | Mohali, Punjab, India | |||
| Marxx Pharma Private Limited | ₹21.23 Cr (FY 2024) | 682.0% | Hisar, Haryana, India | |||
| Ravi Pharmaceuticals Pvt Ltd | ₹21.23 Cr (FY 2024) | 15.0% | Khambhat, Gujarat, India | |||
| Glowsun India Labs Private Limited | ₹21.2 Cr (FY 2024) | 11.0% | Dehradun, Uttarakhand, India |
To see the full peer comparison of Dexbio Pharma Private Limited, buy the company report.
Auditor
Dexbio Pharma Private Limited is audited by SANJAY KUMAR AGARWAL & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY KUMAR AGARWAL & ASSOCIATES | FY 2024 | 002873C |
Shareholding
The shareholding of Dexbio Pharma Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dexbio Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹14.53 Cr
Satisfied charges
₹11.96 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Aug 2025 | 101152326 | Axis Bank Limited | ₹1.95 Cr | Open | |
| 21 Jun 2025 | 101117786 | Axis Bank Limited | ₹3 Cr | Open | |
| 21 Jun 2025 | 101118926 | Axis Bank Limited | ₹3.55 Cr | Open | |
| 17 Nov 2022 | 100642672 | Hdfc Bank Limited | ₹6.03 Cr | Open | |
| 25 Sep 2024 | 100990373 | Canara Bank | ₹4.02 Cr | Satisfied |
To see the full charge records of Dexbio Pharma Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Dexbio Pharma Private Limited has 20 court cases on record: 5 filed by Dexbio Pharma, 15 filed against it. 2 cases are pending and 18 are disposed.
Total cases
20
Filed by the company
5
Filed against the company
15
Pending
2
Disposed
18
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 11 | 2 |
| High courts | 9 | 4 | 0 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West Godavari, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Salem, Tamil Nadu | Criminal case | Filed against the company by State Government, Drug Inspector, Mettur Range, Salem | Pending |
| District court, Sirmaur, Himachal Pradesh | Civil miscellaneous application | Filed against the company by M/S Ziofy Pharmaceuticals | Disposed |
| District court, Sirmaur, Himachal Pradesh | Court case (Suit for Recovery) | Filed against the company by M/S Ziofy Pharmaceuticals | Disposed |
| District court, TUMAKURU, Karnataka | Criminal complaint | Filed against the company by an individual | Disposed |
To see the full case history of Dexbio Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dexbio Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dexbio Pharma Private Limited has a workforce of 27 employees on its EPFO records as of Oct 08, 2025, across 1 active EPFO establishment.
Employee count
27
Active EPFO establishments
1
Employee growth
-10%
GST
Dexbio Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Dexbio Pharma Private Limited, buy the company report.
Recent activity
Dexbio Pharma Private Limited has 9 board changes on record since 2006: 4 appointments and 5 cessations. The latest: Anshul Chhabra ceased to be Additional Director on 30 Sep 2018.
Charges
A charge registered on 04 Apr 2021 via Charge ID 100448815 with Hdfc Bank Limited was fully satisfied on 05 May 2026.
Charges
A charge with Axis Bank Limited of Rs. 300.00 Lakh registered on 21 Jun 2025 with Charge ID 101117786 was modified on 16 Mar 2026.
Charges
A charge with Axis Bank Limited of Rs. 355.00 Lakh registered on 21 Jun 2025 with Charge ID 101118926 was modified on 16 Mar 2026.
Charges
A charge registered on 25 Sep 2024 via Charge ID 100990373 with Canara Bank was fully satisfied on 17 Feb 2026.
AGM
Dexbio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 195.00 Lakh with Charge ID 101152326 was registered on 19 Aug 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 300.00 Lakh with Charge ID 101117786 was registered on 21 Jun 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 355.00 Lakh with Charge ID 101118926 was registered on 21 Jun 2025.
Filing
Dexbio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Charges
A charge with Hdfc Bank Limited of Rs. 491.42 Lakh registered on 04 Apr 2021 with Charge ID 100448815 was modified on 17 Feb 2025.
Charges
A charge with Canara Bank amounted to Rs. 402.00 Lakh with Charge ID 100990373 was registered on 25 Sep 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 603.42 Lakh registered on 17 Nov 2022 with Charge ID 100642672 was modified on 06 Sep 2024.
19 earlier events are in the company report.
Frequently asked questions
Dexbio Pharma is an active private limited company based in Roorkee, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 2006 (20+ years old) and is registered under CIN U24232UR2006PTC011840.
Dexbio Pharma has 4 current directors:
- Venkata Subbarao - Director
- Anshul Chhabra - Director
- Venkata Rangaiah Kothuri - Director
- Rajeev Kumar Chhabra - Director
The latest financial statements of Dexbio Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Dexbio Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Dexbio Pharma is U24232UR2006PTC011840. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dexbio Pharma has 20 court cases on record: 5 filed by the company and 15 filed against it. 2 are pending. Most are in the district courts.
Dexbio Pharma was incorporated on 31 May 2006, making it 20+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Dexbio Pharma by revenue are Sunrise International Labs Limited, Ce-Chem Pharmaceuticals Private Limited, Dios Lifesciences Private Limited, Elfin Drugs Private Limited, Marxx Pharma Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anshul Chhabra ceased to be Additional Director on 30 Sep 2018. Rajeev Kumar Chhabra ceased to be Additional Director on 30 Sep 2018. Anshul Chhabra was appointed as Director on 23 Apr 2018. Dexbio Pharma has 9 board changes on record in total.
Yes, Dexbio Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0004118).
The registered office of Dexbio Pharma is at 1342 Khasra No 4M Shiv Ganga Industrial Estate, Roorkee, Uttarakhand, India – 247667.